loading...| Preferred Name |
Albiglutide |
|
| Synonyms |
|
|
| Definitions |
A long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, with antihyperglycemic activity. Albiglutide is composed of a GLP-1 (7-36) dimer fused to recombinant human albumin. Upon subcutaneous administration, this agent has a half-life of 4-7 days and resists degradation by dipeptidyl peptidase-4 (DPP-4). |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C78128 |
|
| CAS_Registry |
782500-75-8 |
|
| code |
C78128 |
|
| Contributing_Source |
FDA |
|
| definition |
A long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, with antihyperglycemic activity. Albiglutide is composed of a GLP-1 (7-36) dimer fused to recombinant human albumin. Upon subcutaneous administration, this agent has a half-life of 4-7 days and resists degradation by dipeptidyl peptidase-4 (DPP-4). |
|
| FDA_UNII_Code |
5E7U48495E |
|
| in_subset | ||
| label |
Albiglutide |
|
| Legacy Concept Name |
Albiglutide |
|
| Preferred_Name |
Albiglutide |
|
| prefixIRI |
NCIT:C78128 |
|
| prefLabel |
Albiglutide |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C2607479 |
|
| subClassOf |